Literature DB >> 25801572

Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae.

Marcus Ho Yin Wong1, Edward Wai Chi Chan1, Sheng Chen2.   

Abstract

The OqxAB efflux pump, a plasmid-mediated quinolone resistance (PMQR) determinant, has become increasingly prevalent among members of Enterobacteriaceae over the past decade. To investigate the evolution and dissemination routes of the oqxAB operon, we assessed the prevalence of oqxAB-like elements among various Gram-negative bacterial species and analyzed the genotypic and phenotypic characteristics of organisms harboring such elements. With a comprehensive genotyping approach, a chromosome-based oqxAB operon was detectable in all Klebsiella pneumoniae strains tested, including organisms isolated before the year 1984. Sequence and phylogenetic analyses confirmed that the oqxAB operon in K. pneumoniae isolates was genetically closest to their plasmid-borne counterparts recoverable only from Escherichia coli and Salmonella isolates collected from the year 2003 onward. Chromosomal elements with much lower sequence homology were also found among the Enterobacter spp. but not other Gram-negative species. Contrary to the quinolone resistance phenotypes which were consistently observable among organisms with oqxAB-harboring plasmids, chromosomal oqxAB elements generally did not confer quinolone resistance, except for K. pneumoniae strains, which exhibited a typical oqxAB-mediated phenotype characterized by cross-resistance to olaquindox, chloramphenicol, and the quinolones. Gene expression analysis illustrated that such phenotypes were due to elevated expression of the chromosomal oqxAB operon. Furthermore, transposition of the oqxAB operon from the bacterial chromosome to plasmids was found to result in a >80-fold increase in the level of expression of the OqxAB pump, confirming its status as the first constitutively expressed efflux system located in bacterial mobile elements.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801572      PMCID: PMC4432112          DOI: 10.1128/AAC.00310-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Prevalence of qnr, aac(6')-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and the environment.

Authors:  Xiang Chen; Weiqiu Zhang; Weijuan Pan; Jiajun Yin; Zhiming Pan; Song Gao; Xinan Jiao
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

2.  Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae.

Authors:  Mark Veleba; Paul G Higgins; Gerardo Gonzalez; Harald Seifert; Thamarai Schneiders
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

3.  OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin.

Authors:  Federico Perez; Susan D Rudin; Steven H Marshall; Peter Coakley; Liang Chen; Barry N Kreiswirth; Philip N Rather; Andrea M Hujer; Philip Toltzis; David van Duin; David L Paterson; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

4.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Authors:  Koichiro Tamura; Glen Stecher; Daniel Peterson; Alan Filipski; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2013-10-16       Impact factor: 16.240

5.  First detection of oqxAB in Salmonella spp. isolated from food.

Authors:  Marcus Ho Yin Wong; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae.

Authors:  J M Rodríguez-Martínez; P Díaz de Alba; A Briales; J Machuca; M Lossa; F Fernández-Cuenca; J Rodríguez Baño; L Martínez-Martínez; Á Pascual
Journal:  J Antimicrob Chemother       Date:  2012-09-25       Impact factor: 5.790

7.  Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli.

Authors:  Lars Hestbjerg Hansen; Elsebetta Johannesen; Mette Burmølle; Anders Hay Sørensen; Søren J Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux.

Authors:  Anders Norman; Lars Hestbjerg Hansen; Qunxin She; Søren Johannes Sørensen
Journal:  Plasmid       Date:  2008-04-28       Impact factor: 3.466

9.  Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria.

Authors:  Lars Hestbjerg Hansen; Lars Bogø Jensen; Heidi Iskou Sørensen; Søren Johannes Sørensen
Journal:  J Antimicrob Chemother       Date:  2007-05-24       Impact factor: 5.790

10.  Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations.

Authors:  Toyotaka Sato; Shin-Ichi Yokota; Ikuo Uchida; Torahiko Okubo; Msaru Usui; Masahiro Kusumoto; Masato Akiba; Nobuhiro Fujii; Yutaka Tamura
Journal:  Front Microbiol       Date:  2013-05-24       Impact factor: 5.640

View more
  24 in total

1.  Landscape of Resistance-Nodulation-Cell Division (RND)-Type Efflux Pumps in Enterobacter cloacae Complex.

Authors:  François Guérin; Claire Lallement; Christophe Isnard; Anne Dhalluin; Vincent Cattoir; Jean-Christophe Giard
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 2.  Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.

Authors:  B Yanat; J-M Rodríguez-Martínez; A Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-26       Impact factor: 3.267

Review 3.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

4.  Plasmid-mediated quinolone resistance (PMQR) among Enterobacteriales in Latin America: a systematic review.

Authors:  Denize Cristina Vieira; William Gustavo Lima; Magna Cristina de Paiva
Journal:  Mol Biol Rep       Date:  2019-12-07       Impact factor: 2.316

Review 5.  Transferable Mechanisms of Quinolone Resistance from 1998 Onward.

Authors:  Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

Review 6.  Klebsiella oxytoca and Emerging Nosocomial Infections.

Authors:  Nakul Neog; Upasana Phukan; Minakshi Puzari; Mohan Sharma; Pankaj Chetia
Journal:  Curr Microbiol       Date:  2021-03-03       Impact factor: 2.188

7.  Risk Factors, Outcomes, and Mechanisms of Tigecycline-Nonsusceptible Klebsiella pneumoniae Bacteremia.

Authors:  Chih-Han Juan; Yi-Wei Huang; Yi-Tsung Lin; Tsuey-Ching Yang; Fu-Der Wang
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

8.  IncHI2 Plasmids Are the Key Vectors Responsible for oqxAB Transmission among Salmonella Species.

Authors:  Marcus Ho-Yin Wong; Edward Wai-Chi Chan; Liqi Xie; Ruichao Li; Sheng Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 9.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

10.  Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.

Authors:  Muniqui S Capett; Patricia Vollú-Silva; Vanessa A Melchiades; Luciana C Bokehi; Fernanda M Araújo; Ianick Souto Martins; Felipe P G Neves; Alice G M Gonzalez; Eric Oswald; Geraldo R de Paula; Lenise A Teixeira
Journal:  Curr Microbiol       Date:  2016-07-26       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.